Liquid Formulations in Crop Protection and Their Use

Information

  • Patent Application
  • 20070238615
  • Publication Number
    20070238615
  • Date Filed
    April 02, 2007
    17 years ago
  • Date Published
    October 11, 2007
    16 years ago
Abstract
Liquid formulations in crop protection and their use Formulations with delayed release of agrochemical actives from the group of fatty acid synthetase inhibitors are suitable for reducing phytotoxicity in crop plants when said agrochemical actives are used to check unwanted detrimental organisms in the crops.
Description
EXAMPLES
A) FORMULATING EXAMPLES
Example 1a





    • (I) 7.28 g of fenoxaprop-P-ethyl (94.8% D-(+)-isomer) were dissolved in 20.0 g of Solvesso® 200ND, and then 0.5 g of Voranate® M220 (Dow Chemicals, technical-grade methylenediphenyl diisocyanate) was incorporated by stirring until the composition was completely homogeneous.

    • (II) Furthermore, an aqueous solution consisting of 5.0 g of Mowiol® 3-83 (Clariant, polyvinyl alcohol), 4.5 g of Genapol® V4829 (Clariant, ethylene oxide/propylene oxide copolymer), 0.05 g of Rhodorsil® 432 (Rhodia, silicone-based defoamer), 0.01 g of Acticide® MBS (preservative) and 45.0 g of water was prepared.

    • (III) A stirred vessel equipped with dropping funnel and stirring motor/paddle stirrer was charged with the aqueous phase from (II), and the organic phase from (I) was added rapidly with stirring. After about 0.5 h the stirring speed was reduced and an aqueous solution of 0.62 g of hexamethylenediamine in 1 g of water was metered in. Shortly after that, 2.0 g of glycerol (technical grade) were added. Stirring was continued at the same speed for a further 4 h at room temperature and then 15 g of Genapol X-150 (isotridecyl alcohol polyglycol ether with 15 EO) were added. This gave a microcapsule dispersion containing 7.28% fenoxaprop-P-ethyl (see also Table 1).





Example 1b

The procedure of Example 1a was repeated but adding, when preparing the aqueous solution, instead of 15 g of Genapol X-150 (isotridecyl alcohol polyglycol ether with 15 EO), a mixture of 5 g of Genapol X-150 and 10 g of BEHSS-Na [i.e., bis(2-ethylhexyl)sulfosuccinate sodium] (see also Table 1).


Examples 2 to 10

The procedures of Examples 1a and 1b were applied analogously in order to prepare the microcapsule formulations whose compositions are specified in Tables 1 and 2.














TABLE 1





Composition/components
1a
1b
2
3
44)




















FPE
7.28
7.28
0.00
0.00
0.00


Clethodim (92% active
0.00
0.00
7.57
7.57
7.57


content)


Water1)
45.00
45.00
49.73
50.19
50.18


Solvesso 200ND
20.00
20.00
20.00
20.00
20.00


Glycerol, technical-grade
2.00
2.00
2.00
2.00
2.00


Mowiol 3-83 (20%)2)
5.00
5.00
5.00
5.00
5.00


Genapol V4829 (20%)2)
4.50
4.50
4.50
4.50
4.50


Voranate M220
0.50
0.50
0.00
0.00
0.00


TMXDI
0.00
0.00
0.50
0.50
0.65


DETA
0.00
0.00
0.00
0.14
0.00


Hexamethylenediamine
0.62
0.62
0.60
0.00
0.00


(40%)2)


Acticide MBS
0.05
0.05
0.05
0.05
0.05


Rhordorsil 432
0.05
0.05
0.05
0.05
0.05


Genapol X-1503)
15.00
5.00
10.00
10.00
10.00


BEHSS-Na3)
0.00
10.00
0.00
0.00
0.00



100.00
100.00
100.00
100.00
100.00






















TABLE 2





Composition
5
6
7
8
9
104)





















Clethodim (92%)
7.57
7.57
7.57
7.57
7.57
7.57


Water1)
49.73
50.19
50.19
44.73
44.73
45.18


Solvesso 200ND
20.00
20.00
20.00
20.00
20.00
20.00


Glycerol, technical-grade
2.00
2.00
2.00
2.00
2.00
2.00


Mowiol 2-83 (20%)2)
5.00
5.00
5.00
5.00
5.00
5.00


Genapol V4829 (20%)2)
4.50
4.50
4.50
4.50
4.50
4.50


TMXDI
0.50
0.50
0.50
0.50
0.50
0.65


DETA
0.00
0.14
0.14
0.00
0.00
0.00


Hexamethylenediamine (40%)2)
0.60
0.00
0.00
0.60
0.60
0.00


Acticide MBS
0.05
0.05
0.05
0.05
0.05
0.05


Rhordorsil 432
0.05
0.05
0.05
0.05
0.05
0.05


Emulsogen EL4003)
0.00
0.00
0.00
0.00
0.00
5.00


BEHSS-Na3)
0.00
0.00
0.00
10.00
10.00
10.00


Genapol X-1503)
0.00
0.00
0.00
5.00
0.00
0.00


Genapol X-150-Me3)
0.00
0.00
10.00
0.00
0.00
0.00


Genapol X-0603)
10.00
0.00
0.00
0.00
5.00
0.00


Genapol X-060-Me3)
0.00
10.00
0.00
0.00
0.00
0.00



100.00
100.00
100.00
100.00
100.00
100.00





Notes and further abbreviations for Tables 1 and 2:


Notes:



1)Residual water (total water content = residual water content + fractions of water in the individual components)




2)In each case as an aqueous solution




3)Addition in each case after formation of microcapsules




4)Capsule formation without diamines or polyamines at elevated temperature (70° C.)







Further abbreviations for Tables 1 and 2:

    • Acticide MBS Bactericide solution including 1,2-benzisothiazol-3(2H)-one and 2-methyl-2H-isothiazol-3-one as active ingredients
    • DETA Diethylenetriamine
    • Emulsogen EL400 Castor oil ethoxylate with 40 EO
    • BEHASS-Na Bis(2-ethylhexyl)sulfosuccinate Na
    • Genapol X-150 Isotridecyl alcohol polyglycol ether with 15 EO
    • Genapol X-150-Me Modified isotridecyl alcohol polyglycol ether with 15 EO (terminally etherified with methanol)
    • Genapol X-060 Isotridecyl alcohol polyglycol ether with 6 EO
    • Genapol X-060-Me Modified isotridecyl alcohol polyglycol ether with 6 EO (terminally etherified with methanol)
    • Genapol V4829 Block copolymer of ethylene oxide and propylene oxide
    • Mowiol 3-83 Polyvinyl alcohol, partially hydrolyzed (Clariant)
    • Rhodorsil 432 Silicone emulsion (defoamer from Rhodia)
    • Solvesso 200 ND Aromatic mineral oil (boiling range 219-281° C.)
    • TMXDI α,α,α′,α′-Tetramethyl-m-xylylene diisocyanate, also called 1,3-bis(1-isocyanato-1-methylethyl)benzene
    • Voranate M220 Methylene diisocyanate


Further information on preparation:


The size (particle size) of the microcapsules prepared is generally less than 50 μm, as a rule less than 20 μm, and preferably less than 15 μm. Preferred microcapsule suspensions contain microcapsules having a particle size distribution, measured on the basis of the d(10) particle diameter in the range up to 4 μm, in particular up to 1.5 μm, or measured on the d(50) particle diameter in the range up to 10 μm, in particular up to 5 μm, or measured on the d(90) particle diameter in the range up to 15 μm, in particular up to 10 μm.


The indications d(10), d(50), and d(90) here mean that 10%, 50%, and 90%, respectively, of the particles (fractions based on the volume) are smaller in diameter than that stated size in μm. The d50 value can be considered approximately as an average value of the diameter (though does not correspond exactly to the mathematical average), the indications of the three values d(10), d(50), and d(90) together being used as a measure of the breadth of distribution, or polydispersity of the distribution (strongly monodisperse is represented by d10=d50=d90). The values d(10), d(50), and d(90) for the capsule diameter can be determined for example by means of a laser diffraction spectrometer, an example being the instrument Coulter LS230.


Further formulating examples for microcapsule formulations (CS formulations)


In analogy to the methods given it is also possible to encapsulate further actives (other than fatty acid synthetase inhibitors) and to combine them with encapsulated fatty acid synthetase inhibitors, by means for example of a coformulation, or in the spray liquor.


In coformulations the fatty acid synthetase inhibitors may be microencapsulated together with or separately from other agrochemical actives.


Where they are separately microencapsulated, coformulations may for example also be obtained by the mixing of two or more microcapsule formulations each containing different actives.


Where the different actives are to be microencapsulated together, it is possible by way of example to dissolve all of the actives in solution, to prepare an emulsion from this solution, and then to microencapsulate the droplets of the emulsion.


All of the CS formulations described can be prepared by the same process, i.e., with comparable wall materials, comparable capsule dimensions, as measured by d(10), d(50), and d(90) (see elucidations earlier on above), and comparable ratio of organic phase to wall material. The loading of the CS formulation with “encapsulated” actives (fatty acid synthetase inhibitors and optional other agrochemical actives) is preferably in the range from 0.3% to 70% by weight.


B) BIOLOGICAL EXAMPLES

Postemergence Application


Postemergence Weed Activity


Rice plant seedlings and typical rice weeds were cultivated under glass under Paddy rice conditions (water level: 2-3 cm) in pots under good growth conditions (temperature, humidity, water supply) and were treated at the two to three leaf stage with the actives. The actives, formulated as CS formulations or as oil-in-water emulsions, were sprayed at various dosages onto the green plant parts at an application rate of 300 l of water per ha (converted). After the test plants had stood under glass under optimum growth conditions for approximately 3 to 4 weeks, the activity of the products was scored visually in comparison to untreated controls. The scoring covered damage and development of all above-soil plant parts. Scoring was carried out on a percentage scale (100% activity=all plants died; 50% activity=50% of the plants and green plant parts died; 0% activity=no discernible activity=same as control). Results are summarized in Table 3.


The experiment shows that the CS formulation has a comparable activity on the weeds in combination with an improved crop plant tolerance.









TABLE 3







Application of herbicides against weeds in rice













Rice





Herbicide
ORYSA
Weeds













Formulation
g Al/ha
Balilla
DIGSA
ECHCG

















Standard EW
90
40
100
100




45
40
85
100



CS formulation
90
15
95
100




45
10
95
100







Abbreviations:



Al = active ingredient (=based on 100% active)



Standard EW = standard oil-in-water formulation of fenoxaprop-P-ethyl (Whip)



CS formulation = microcapsule formulation of fenoxaprop-P-ethyl according to Example 1a of Table 1 (see Formulating Examples)



ORYSA = Oryza sativa (rice)



DIGSA = Digitaria sativa



ECHCG = Echinochloa crus-galli





Claims
  • 1. A method for reducing phytotoxicity of agrochemical actives from the group of fatty acid synthetase inhibitors in crop plants wherein a delayed-release formulation of the agrochemical actives is used when said agrochemical actives are used for controlling unwanted detrimental organisms in crops of said crop plants.
  • 2. The method as claimed in claim 1, wherein the formulation is a microcapsule formulation or a wax dispersion.
  • 3. The method as claimed in claim 2, wherein the formulation is a microcapsule formulation containing a) 0.3 to 60 weight percent of one or more actives from the group of fatty acid synthetase inhibitors, wholly or partly microencapsulated,b) 5 to 80 weight percent of organic solvents or solvent mixtures,c) 5 to 80 weight percent of water,d) 0 to 30 weight percent of one or more aromatic or nonaromatic surfactants,e) 0 to 30 weight percent of one or more dispersants for physical stabilization,f) 0 to 50 weight percent of further agrochemical actives, andg) 0 to 30 weight percent of further formulating auxiliaries.
  • 4. The method as claimed in claim 3, the formulation containing a) 0.3 to 60 weight percent of one or more actives from the group of fatty acid synthetase inhibitors, wholly or partly microencapsulated,b) 5 to 60 weight percent of organic solvents or solvent mixtures,c) 10 to 60 weight percent of water,d) 2 to 30 weight percent of one or more aromatic or nonaromatic surfactants,e) 0.5 to 30 weight percent of one or more dispersants for physical stabilization,f) 0 to 30 weight percent of further agrochemical actives, andg) 0 to 30 weight percent of further formulating auxiliaries.
  • 5. The method as claimed in claim 4, the formulation containing a) 0.3 to 60 weight percent of one or more actives from the group of fatty acid synthetase inhibitors, wholly or partly microencapsulated,b) 10 to 60 weight percent of organic solvents or solvent mixtures,c) 20 to 50 weight percent of water,d) 2 to 20 weight percent of one or more aromatic or nonaromatic surfactants,e) 0.5 to 20 weight percent of one or more dispersants for physical stabilization,f) 0 to 20 weight percent of further agrochemical actives, andg) 2 to 20 weight percent of further formulating auxiliaries.
  • 6. The method as claimed in claim 1, wherein the agrochemical active is an ACCase inhibitor.
  • 7. The method as claimed in claim 1, wherein the agrochemical active is an active from the group of phenoxyphenoxy- and (heteroaryloxyphenoxy)-alkanecarboxylic acids and their esters and salts, cyclohexanedione oximes, and ketoenols.
  • 8. The method as claimed in claim 7, wherein the agrochemical active is selected from the group consisting of fenoxaprop-P-ethyl, fenoxaprop-ethyl, diclofop-methyl, diclofop-P-methyl, clodinafop-propargyl, cyhalofop-butyl, fluazifop-P-butyl, haloxyfop, haloxyfop esters, haloxyfop-P, haloxyfop-P esters, metamifop, propaquizafop, quizalofop, quizalofop esters, quizalofop-P, quizalofop-P esters, cycloxydim, clethodim, butroxydim, alloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim and pinoxaden.
  • 9. The method as claimed in claim 2, wherein one or more solvents from the group consisting of aliphatic and aromatic hydrocarbons, halogenated aliphatic and aromatic hydrocarbons, monobasic and polybasic esters, alkylene glycol monoalkyl and dialkyl ethers, cyclohexanone, isophorone, oils of natural origin, and their transesterification products are used.
  • 10. The method as claimed in claim 2, wherein one or more surfactants from the group consisting of sulfosuccinate-based surfactants and nonionic surfactants and also mixtures of nonionic surfactants and of sulfosuccinate-based surfactants are used.
  • 11. The method as claimed in claim 2, wherein one or more dispersants from the group consisting of polyvinyl alcohols, polyalkylene oxides, condensation products of formaldehyde with naphthalenesulfonic acids and/or phenols, polyacrylates, copolymers of maleic anhydride with alkylene alkyl ethers, ligninsulfonates, and polyvinylpyrrolidones are used.
  • 12. The method as claimed in claims 2, wherein the microcapsules have a d(90) particle size of below 50 μm.
  • 13. The method as claimed in claim 1, wherein the agrochemical active is applied in the form of a controlled-release formulation to the plants, parts of plants, their seed or the cultivation area.
  • 14. The method as claimed in claim 1, wherein the agrochemical active is applied in a controlled-release formulation to the plants, parts of plants, their seed or the cultivation area.
Priority Claims (1)
Number Date Country Kind
10 2006 015 940.3 Apr 2006 DE national